You are here

cancer

To focus on cancer, Chimerix sells rights to antiviral drug that defined the biotech

MedCity News

Tue, 05/17/22 - 10:46 am

A week after disclosing layoffs, BridgeBio nets a $90M upfront cancer R&D pact with Bristol Myers

Endpoints

Thu, 05/12/22 - 10:24 am

Bristol Myers Squibb

Against a historic market downturn, Moma Therapeutics raises $150M for precision cancer research

BioPharma Dive

Wed, 05/11/22 - 10:51 am

MOMA Therapeutics

Gilead dives deeper into NK cell therapies with Dragonfly deal

Pharmaforum

Tue, 05/3/22 - 10:37 am

Gilead Sciences

natural killer cells

Dragonfly Therapeutics

FDA guidance machine churns out 8 new documents in less than a week

Endpoints

Mon, 05/2/22 - 06:17 pm

ulcerative colitis

Crohn's Disease

clinical trials

FDA’s Cancer Advisory Committee to Evaluate Safety of PI3K inhibitors

BioSpace

Wed, 04/20/22 - 11:19 pm

Gilead, after setbacks, aims to pull a third of its revenue from oncology business by 2030

Fierce Pharma

Mon, 04/18/22 - 11:47 pm

Gilead Sciences

AbbVie preps filings for lymphoma bispecific licensed from Genmab

Pharmaforum

Thu, 04/14/22 - 10:39 am

large B-cell lymphoma

Covid vaccines didn’t work for many cancer patients — but researchers are designing a new shot for them

Stat

Wed, 04/13/22 - 10:50 am

Triana Raises $110M to Solve Undruggable Cancer Targets with Molecular Glue

BioSpace

Fri, 04/8/22 - 10:25 am

Triana Biomedicines

drug development

Sunshine Biopharma's Stock Scorches with Promising mRNA Molecules for Cancer

BioSpace

Thu, 04/7/22 - 05:59 pm

Sunshine Biopharma

Silverback falls on hard times, axing lead I/O candidates and laying off more than a fourth of staff

Endpoints

Fri, 04/1/22 - 10:35 am

Silverback Theraepeutics

immuno-oncology

Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab

BioSpace

Tue, 03/29/22 - 10:53 am

IGM Biosciences

4D Pharma: New data early indication LBPs may help to overcome resistance to checkpoint inhibitors

Biopharma Reporter

Tue, 03/29/22 - 10:49 am

live biotherapeutics

Cancer drug prices rise in the US despite an increasingly competitive market — report

Endpoints

Sun, 03/27/22 - 03:51 pm

Bristol Myers sues AstraZeneca over cancer-treatment patents

Reuters

Mon, 03/21/22 - 10:08 am

Bristol Myers Squibb

Bristol Myers lands $1.1B biobucks oncology pact with Volastra, a biotech with phones 'ringing off the hook'

Fierce Biotech

Mon, 03/21/22 - 10:06 am

chromosomal instability

Bristol Myers Squibb

Precision oncology startup AnHeart Therapeutics co-founder shares cancer drug strategy

MedCity News

Mon, 03/21/22 - 10:05 am

AnHeart Therapeutics

precision oncology

precision medicine

Four Cancer Clinical Trials Advance with Blessing of FDA

BioSpace

Wed, 03/16/22 - 11:23 pm

clinical trials

Sonnet BioTherapeutics

pancreatic cancer

Sanofi steps off the sidelines to ink 3 ADC deal with Seagen, reigniting long-held interest in the modality

Fierce Biotech

Wed, 03/16/22 - 10:38 am

antibody-drug conjugate

Pages